Tenon Medical Inc (NAS:TNON)

Q2 2026 Tenon Medical Inc Earnings Call Transcript

Aug 13, 2026 / 08:30 PM GMT

Release Date Price: $5.96 (+5.67%)

Transcript 10-Q8-K

Key Points

Positve

Second quarter revenue increased 127% year-over-year to $1.3 million, a record for the period.
Gross margin expanded significantly to 64% in Q2 2026, up from 43% in Q2 2025.
Received FDA 510(k) clearance for the Catamaran SI joint fusion system, with instrument upgrades expected to reduce per-procedure costs and improve margins.
Training events increased 98% in the first half of 2026 compared to the second half of 2025, driving record case volume in July.
Closed a $4.2 million public offering in July 2026, providing additional capital to fund commercial expansion and R&D initiatives.

Negative

Net loss widened to $4.1 million in Q2 2026 from $2.8 million in Q2 2025, partly due to non-cash interest expense on convertible notes.
Cash and cash equivalents declined to $1.7 million as of June 30, 2026, from $3.8 million at the end of 2025.
Operating expenses increased to $4.2 million in Q2 2026 from $3.1 million in Q2 2025, driven by higher sales and marketing and R&D costs.
The company continues to report significant operating losses, with a six-month loss from operations of $6.6 million, essentially unchanged year-over-year.
Dependence on future product launches and regulatory approvals (e.g., enhanced Symmetry Plus features) to sustain growth, which carry execution and timing risks.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TNON.OQ - Tenon Medical Inc
Q2 2026 Tenon Medical Inc Earnings Call
Aug 13, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Tennant Medical Second Quarter 2026 Financial Results and Corporate Update Conference Call.

As a reminder, this call is being recorded.

Your hosts today are Steve Foster, President and Chief Executive Officer, and Kevin Williamson, Chief Financial Officer.

Mr. Foster and Mr. Williamson will present results of operations for the second quarter ended June 30, 2026, and provide a corporate update.

A press release detailing these results was released today and is available on the Investor Relations section of our company's website, www.tenemedmed.com.

Before we begin the formal presentation, I would like to remind everyone that statements made on the call and webcast

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.